Vera Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | -50.7% | -29.9% | -580.7% | – | – | +345.7% | |
| – | +25.9% | +810.0% | +195.1% | +29.3% | +81.0% | +82.3% | |
| – | +3,271.7% | -103.7% | – | – | – | – | |
| – | -76.2% | +2,754.5% | +92.2% | -187.0% | – | +764.4% | |
| – | -20.8% | -100.0% | – | +1.6% | +1,442.9% | -35.2% | |
| – | -66.4% | +9,909.5% | +1,578.2% | -44.1% | +977.9% | – | |
| – | – | – | -95.7% | -100.0% | – | -100.0% | |
| – | – | -10.1% | +302.7% | +24.9% | -100.0% | – | |
| – | – | -36.8% | +89.2% | +31.0% | +354.3% | -49.1% | |
| – | – | -48.5% | -239.4% | – | +2,334.7% | +458.0% | |
| – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.